I'm excited to start a new chapter

National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations @theNCI #BCR #ProstateCancer #ClinicalTrial https://t.co/ePbf8j7KQU

For those out there with less gray hair than me… Never underestimate the value in working with good people towards a common goal. You can always do more together Sometimes academia makes us forget that science is a team sport & no one does anything alone #ESMO25 @myESMO

🔔Join us this morning at the virtual @SylvesterCancer 2025 #ClinicalTrialsCourse I will be speaking on importance of #communityengagement and addressing population needs when designing a trial. 🎯If your trial does not enroll the target population , it won’t succeed. 👉🏽Sign up

Vitamin B12 for prophylaxis of capecitabine-associated hand–foot syndrome 💥Oral methylcobalamin reduced capecitabine-related HFS in HER2-negative early BC, with no added safety concerns 💬A simple prophylaxis option to support treatment adherence https://t.co/khCOH0RDv7

We had the honor of inviting Sylvester patient Donica Stephens to join us at the @Marlins Prostate Cancer Awareness Game. 🙌 Donica first met with Dr. Sanoj Punnen (@sanojpunnen) at the @dsui_miami_uro, part of @UMiamiHealth, and was later referred to Sylvester medical

#Metformin study reveals weight management benefits for ADT therapy. @Silke_Gillessen and @neerajaiims discuss the results of the #STAMPEDE trial's metformin arm. The phase 3 trial evaluates the addition of metformin to ADT in patients with #mHSPC. #FullVideo on UroToday >

Hot off the press... Overcoming common emerging barriers to effective neoadjuvant immunotherapies: Expert Review of Anticancer Therapy: Vol 0 , No ja - Get Access

Abs#45 @asco #GU25 Prelim data shows near term metastatic progression (conventional imaging) is a rare event in #PSMA+ #BCR #ProstateCancer Are we overtreating pts w/ median age of 70+ based on lack of understanding of #PSMA? This study continues… https://t.co/7hwIxW2ra9

“Truqap combination (w/abiraterone) in #PTEN -deficient #mCSPC #ProstateCancer demonstrated statistically significant & clinically meaningful improvement in rPFS in #CAPItello-281 Phase III trial” Look forward to seeing this data & relative toxicity

We are hiring a postdoc. If you want to learn more/apply please visit https://t.co/Imdppp9TCT

Online Now: Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer https://t.co/xgPmdLORat

How does a cancer vaccine work?

I received a $100.00 donation supporting Dolphins Challenge Cancer!

I received a $100.00 donation supporting Dolphins Challenge Cancer!

I received a $50.00 donation supporting Dolphins Challenge Cancer!

I received a $50.00 donation supporting Dolphins Challenge Cancer!

Where the magic ✨happens at @SylvesterCancer Experimental Therapeutics/Phase 1 Clinic this morning with @mbilusic @JaimeMerchan10 #researchmatters -#lcsm

Articles in Press: Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide https://t.co/ajMr49DfQq @mbilusic @aj_weisman @radiolobt @billdahutmd @WilliamFigg1 @Dr_RaviMadan

#Genetic testing could be a game changer when it comes to #cancer testing and prevention. Learn from Sylvester #oncology experts @abedsinno, @mbilusic and @CarmenCalfa how the #science is being used for the best patient outcomes.

I received a $200.00 donation supporting Dolphins Challenge Cancer!